Genicular Nerve Block in Chronic Knee Osteoarthritis
Key facts
- Who runs it
- Haydarpasa Numune Training and Research Hospital
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 81 people enrolled
- Started
- 1 Apr 2023
- Ended
- 1 Jul 2024
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Genicular nerve block with prilocaine
- genicular nerve block with prilocaine and triamcinolone
- Sham injection
- Record updated
- 28 November 2025
Who can take part
- Age
- 45 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- age between 45 and 75
- diagnosed with knee osteoarthritis (OA) according to the American College of Rheumatology (ACR) criteria
- possessing a Kellgren-Lawrence radiological grade of 2-3
Who cannot take part
- physical therapy for the target knee within the last 3 months
- previous knee surgery
- inflammatory rheumatic diseases
- neurological disorders (e.g., Alzheimer's or dementia)
- uncontrolled cardiopulmonary diseases
- active malignancy
- any joint injection to the target knee in the past 3 months
- active lumbar radiculopathy on the same side
- pregnancy or lactation
- obesity (body mass index [BMI] >35)
- presence of a pacemaker
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to evaluate whether genicular nerve block (GNB) is effective in reducing pain in patients with knee osteoarthritis. It will also assess the comparative efficacy of different injection protocols.
Read full original descriptionShow less
The main questions it aims to answer are:
Does genicular nerve block with corticosteroid and local anesthetic provide superior pain relief compared with local anesthetic alone or placebo?
Are there differences in clinical outcomes between the three treatment groups?
Researchers will compare three groups:
GNB with corticosteroid plus local anesthetic
GNB with local anesthetic alone
Sham procedure with saline (placebo control)
Participants will:
Receive the assigned injection protocol in accordance with their group
Be evaluated at baseline and scheduled follow-up visits for pain intensity and functional status
Report their pain scores and functional limitations using standardized assessment tools
The 3 groups in the trial
- genicular nerve block with local anestheticExisting treatment, for comparison
Group 1 (GNB with local anesthetic only): Patients received a genicular nerve block (GNB) with 6 mL of 2% prilocaine and participated in a knee exercise program.
Treatment: Genicular nerve block with prilocaine
- genicular nerve block with local anesthetic and corticosteroidExisting treatment, for comparison
Group 2 (GNB with local anesthetic and corticosteroid): Patients received GNB with 5 mL of 2% prilocaine in combination with 1 mL/40 mg of triamcinolone and followed the same exercise regimen.
Treatment: genicular nerve block with prilocaine and triamcinolone
- sham injection with salineSham treatment, for comparison
Group 3 (Control group): Patients received a placebo injection (6 mL of 0.9% saline) with the knee exercise program.
Treatment: Sham injection
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effectiveness of Genicular Nerve Block on Pain and Disability in Chronic Knee Osteoarthritis: A Randomized Controlled Trial
- Record updated
- 28 November 2025